Caris Life Sciences, Inc. (CAI) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Caris Life Sciences, Inc. (CAI) closed at USD 30.25 on 2026-10-14, a change of -0.4 % over the past year, with a market capitalization of USD 8.98B.

Caris Life Sciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Caris Life Sciences, Inc. key figures

Previous close

USD 30.25 (2026-10-14)

1-year change

-0.4 %

Market cap

USD 8.98B

Enterprise value

USD 8.63B

P/E ratio (trailing)

17.45

P/E ratio (forward)

85.40

EPS (trailing)

1.82

EPS (forward)

0.37

PEG ratio

n/a

Price to book

15.17

Revenue growth

45.4 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.68

Employees

1,846

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Caris Life Sciences, Inc. and compare it with other stocks.